1290191-64-8 Usage
General Description
Tert-butyl N-[(1R,3R)-3-hydroxycyclopentyl]carbamate is an organic compound with the molecular formula C11H21NO3. It is a carbamate derivative and is structurally related to tert-butyl carbamate. The compound contains a cyclopentane ring with a hydroxyl group attached to the third carbon, and a tert-butyl group attached to the nitrogen atom. Tert-butyl N-[(1R,3R)-3-hydroxycyclopentyl]carbamate is used in organic synthesis as a protecting group for amines, allowing for selective manipulation of functional groups in complex molecules. It is also used in pharmaceutical research and drug development as a building block for the synthesis of various biologically active compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 1290191-64-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,9,0,1,9 and 1 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1290191-64:
(9*1)+(8*2)+(7*9)+(6*0)+(5*1)+(4*9)+(3*1)+(2*6)+(1*4)=148
148 % 10 = 8
So 1290191-64-8 is a valid CAS Registry Number.
1290191-64-8Relevant articles and documents
Novel Imidazo[4,5-c]Quinoline And Imidazo[4,5-c][1,5]Naphthyridine Derivatives As LRRK2 Inhibitors
-
Paragraph 0176, (2017/04/04)
The present invention provides novel imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine derivatives of Formula (I), and the pharmaceutically acceptable salts thereof wherein R1, R1a, R1b, R2, R4, R5, R6, X and Z are as defined in the specification. The invention is also directed to pharmaceutical compositions comprising the compounds of Formula (I) and to use of the compounds in the treatment of diseases associated with LRRK2, such as neurodegenerative diseases including Parkinson's disease or Alzheimer's disease, cancer, Crohn's disease or leprosy.
